Defective tumor necrosis factor release from Crohn's disease macrophages in response to toll-like receptor activation: Relationship to phenotype and genome-wide association susceptibility loci

Author： Sewell Gavin W.   Rahman Farooq Z.   Levine Adam P.   Jostins Luke   Smith Philip J.   Walker Ann P.   Bloom Stuart L.   Segal Anthony W.   Smith Andrew M.  

Publisher： Blackwell Publishing

ISSN： 1078-0998

Source： Inflammatory Bowel Diseases, Vol.18, Iss.11, 2012-11, pp. : 2120-2127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Toll-like Receptor 4 Mediates LPS-Induced Release of Nitric Oxide and Tumor Necrosis Factor- by Embryonal Cardiomyocytes: Biological Significance and Clinical Implications in Human Pathology

By  

Current Pharmaceutical Design, Vol. 16, Iss. 7, 2010-03 ,pp. : 766-774

Bentham Science Publishers

Access to resources Recommend Favorite

Oxymatrine inhibits lipopolysaccharide-induced inflammation by down-regulating Toll-like receptor 4/nuclear factor-kappa B in macrophages

By Zhang Yu   Yan Ruhong   Hu Yae  

Canadian Journal of Physiology and Pharmacology, Vol. 93, Iss. 4, 2015-01 ,pp. : 253-260

NRC Research Press

Access to resources Recommend Favorite

Insight from genome-wide association studies into coronary heart disease

By Hoffmann Michael M   Renner Wilfried  

Pharmacogenomics, Vol. 13, Iss. 4, 2012-03 ,pp. : 361-363

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Crohn’s Disease

By Shetty A.   Forbes A.  

American Journal of PharmacoGenomics, Vol. 2, Iss. 4, 2002-01 ,pp. : 215-221

Adis International

Access to resources Recommend Favorite

Activation of adenosine A 3 receptors on macrophages inhibits tumor necrosis factor-

By McWhinney C.D.   Dudley M.W.   Bowlin T.L.   Peet N.P.   Schook L.   Bradshaw M.   De M.   Borcherding D.R.   Edwards C.K.  

European Journal of Pharmacology, Vol. 310, Iss. 2, 1996-08 ,pp. : 209-216

Elsevier

Access to resources Recommend Favorite